AMRUTANJAN HEALTH CARE LTD. presented its investor update for Q3 FY25, showing strong growth in key categories, notably 7.2% volume growth compared to the OTC head category's average of 6.4%. Overall, the company announced significant growth in both its value and volume metrics for the body segment, surpassing industry averages.